
Completing the picture of a TB-free world
We’re thrilled to announce the 2023 edition of the Global TB Summit. The summit this year is:
- On October 17–19
- Online and on-site in London (October 19)
- Free to register and attend
- CPD- and CME-accredited
Embracing the theme "Tackling TB together: From awareness to action," our goal this year is to bridge the gap between knowledge and tangible measures for TB management — piece by piece.
Are you ready to piece together a complete picture of a TB-free world with us?
Join us as we tackle TB at the Global TB Summit 2023 — piece by piece.
Can’t attend live? No worries. Register now, and we'll send you the recording after the event.
From awareness to action: What does it mean?
Together, we'll complete the picture of a TB-free world, starting with spreading awareness and culminating in impactful actions. Join us on this incredible journey.
Reasons to attend Global TB Summit 2023
Program: All talks at a glance
Browse through the agenda for this year's program. If you can't make it to the live event on October 17–19, no worries. You'll have the chance to watch all the talks on-demand at your own convenience.
Time (in CET) | Topic | Speaker |
14:00–14:15 | Welcome to Day 1 | Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College, England |
14:15–14:45 | Tuberculosis prevention and care across countries: WHO’s guidelines and recourses |
Dr. Andrei Dadu, Medical Officer, Tuberculosis Unit (TBU), WHO |
14:45–15:15 | Ending TB by 2035 – community effort, advances in science and innovation and financial support |
TBA |
15:15–15:45 | TB and forced displacement – actual landscape | TBA |
15:45–16:15 | The health of forced migrants – social system & communities | TBA |
16:15–16:45 | Emerging Tools and concepts in TB laboratory diagnostics – Whole Genome Sequence/NGS |
Prof. Tim Walker, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam |
16:45–17:15 | Novel short regiments: Truncate TB Trial – 2 months regime |
Prof. Nick. Paton, School of Medicine, NUHS, Singapore |
17:15–17:45 | Biomarkers and novel tests for TB risk, active TB disease and treatment response |
Prof. Jayne Sutherland, Head of the TB Case-Contact Platform, MRC Gambia, LSHTM, England |
17:45–18:00 | Recap and close of Day 1 |
Time (in CET) | Topic | Speaker |
09:00–09:10 | Welcome to Day 2 (APEC) | Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College, England |
09:10–09:40 | Isoniazid monoresistance – does it matter? | Prof. Jann-Yuan Wang, Division of Chest, Department of Internal Medicine, National Taiwan University Hospital |
09:40–10:10 | Tuberculosis trends and national policies in South Korea and financial support |
Prof. Min Jin Soo, Seoul St. Mary’s Hospital, Member of Private Public Mix (PPM), Tuberculosis Control Program, South Korea |
10:10–10:50 | Prevalence of Diabetes Mellitus among patients with TB in Korea, a nationwide cohort study |
Prof. Kang Young Ae, Pulmonologist, Yonsei University Health System Severance Hospital, South Korea |
10:50–10:55 | Break | |
10:55–11:40 | The evolution and evidence-based approach to assess the risk of tuberculosis among visitors and migrants to Australia |
Dr. Gabriella Scandurra, Chief Research Officer, University of Sydney, Australia |
11:40–12:10 | TB & pediatrics | Dr. Nakahashi, Amagasaki Medical Center Pediatrics, Hyogo, Japan |
12:10–12:40 | Enhancing access to TB infection testing using IGRA – a collaborative approach |
Dr. K.S. Sachdeva, Regional Director, International Union Against TB and Lung Disease (The Union), India |
12:40–12:50 | Recap and close (APEC) | |
14:00–14:15 | Welcome to Day 2 (Americas) | |
14:15–14:45 | Cost Effectiveness of IGRAs and testing implementation |
Prof. Jonathan Golub, Prof. of Medicine, Epidemiology and International Health, Johns Hopkins University, USA |
14:45–15:15 | An overview of the latent TB landscape in the US |
TBA |
15:15–15:45 | TB and pediatrics | Dr. Leonardo Martinez, Assistant Professor in the Department of Epidemiology at Boston University, USA |
15:45–16:15 | Migrant & Refugee Testing – preventing TB in an ever-changing population |
Dr. Alawode Oladele, Consultant Physician, Emory University Hospital, USA |
16:15–17:00 | Break | |
17:00–17:30 | Expanding access to detect, test and treat TB |
TBA |
17:30–18:00 | Multi-sectoral engagement towards ending TB Brazil |
Dr. Nicole Menezes de Souza, Technic Consultant, National TB Program and Control, Brazil |
18:00–18:30 | First steps and challenges – IGRA laboratory network implementation to detect LTBI in Sao Paulo/Brazil |
Dr. Erica Chimara Silva, microbiologist and scientific researcher at Institute Adolfo Lutz (IAL), Head of the Tuberculosis and Mycobacteriosis Lab |
18:30–19:00 | Community efforts to prevent TB | Dr. Matthew Sunders, Clinical Fellow, NIHR and Collaborator at the Universidad Peruana Cayteano Heredia and Universidad Privada Boliviana |
Time (in CET) | Topic | Speaker |
10:15–10:30 | Welcome to Day 3 | Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College, England |
10:30–11:00 | TB Nation history - from respiratory sanatoriums, the evolution of diagnosis methods and actual unmet needs |
TBA |
11:00–11:45 | Retaking the fight against TB after the COVID-19 pandemic |
Dr. Esther Robinson, Head of the TB Unit, UK Health Security Agency, England and Lynn Altass, National TB Program Manager, NHS, England |
11:45–12:15 | An update on MDR TB therapies – PRACTECAL and ZENIX studies |
Dr. Nyang’wa, Medical Director, Médecins Sans Frontières Operational Centre Amsterdam, Netherlands |
12:15–12:45 | Break | |
12:45–13:15 | TB and HIV | Prof. Robert Wilkinson, Infectious Disease Consultant, Imperial College London, England |
13:15–13:45 | Immune check-point inhibitors and TB: An under-appreciated risk? |
Prof. Paul Elkington, Respiratory Physician, South Hampton University, England |
13:45–14:15 | Causes, timings and clinical features of tuberculosis-associated deaths in a low-incidence country |
Dr. Jessica Barrett, Imperial College London, England |
14:15–15:30 | Networking and lunch | |
15:30–16:00 | TB and pediatrics | Dr. James Seddon, Consultant Respiratory Physician, Imperial College London, England |
16:00–16:30 | Prevalence and factors associated with TB among the mining communities |
TBA |
16:30–17:30 | TB case studies (3 cases – 20 min each) | Dr. Ed Moran, Consultant in Infectious Disease, North Bristol Hospital, England Dr. Moerida Belton, Consultant Respiratory Physician, Queen Elizabeth Hospital, England Dr. Anne Dunleavy, Consultant Respiratory Physician, St. Georges University Hospital, England |
17:30–17:50 | Coffee break | |
17:50–18:20 | TB victims: lives affected by TB | TBA |
18:20–18:35 | A tribute to nurses: highlighting their dedication to fight TB |
TBA |
18:35–18:45 | Final remarks and close of the summit |
Meet the speakers
Want to connect with TB experts and advocates and learn the latest about TB?
Join us as we tackle TB at the Global TB Summit 2023 — piece by piece.
Can’t attend live? No worries. Register now, and we'll send you the recording after the event.